NCT04041050 2025-02-14A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmAbbViePhase 1 Active not recruiting85 enrolled
NCT01313429 2020-03-03Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or MediastinumNational Institutes of Health Clinical Center (CC)Phase 1 Terminated19 enrolled
NCT00081848 2017-07-02Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid TumorsNational Institutes of Health Clinical Center (CC)Phase 1 Completed12 enrolled
NCT00581971 2013-04-25RAD0201University of Alabama at BirminghamPhase 1/2 Completed30 enrolled 8 charts